Document Detail

The parkinsonian phenotype of spinocerebellar ataxia type 2.
MedLine Citation:
PMID:  14732617     Owner:  NLM     Status:  MEDLINE    
BACKGROUND: We recently reported that spinocerebellar ataxia type 2 (SCA2) caused familial parkinsonism in 2 brothers with predominant symptoms of resting tremor, rigidity, and bradykinesia that responded to levodopa. OBJECTIVE: To investigate SCA2 as the possible cause of familial parkinsonism in our series and subsequently to analyze the correlation between the clinical manifestation and CAG repeat size in the ataxin-2 gene product. PATIENTS: One hundred thirty patients from 41 families with familial parkinsonism were examined for SCA2. Another 8 patients with the classic ataxic phenotype of SCA2 from 6 families were the control group. DESIGN: The length of expanded CAG repeat was analyzed by means of polymerase chain reaction. The clinical data and genetic findings in the parkinsonian phenotype were then compared with those in the ataxic phenotype. RESULTS: We found expanded CAG repeats in the ataxin-2 gene product in 7 patients from 4 families with parkin-sonism, which was about 10% of our familial parkinsonism series. The parkinsonian phenotype was characterized by resting tremor, rigidity, and bradykinesia. Only mild dysarthria, ataxic gait, and instability were noted, particularly in the late stage. Patients with the parkinsonian phenotype had an older mean +/- SD age of symptom onset (45.8 +/- 13.9 years) and shorter mean +/- SD abnormal CAG length (36.2 +/- 1.1 repeats) than did those with the ataxic phenotype (26.9 +/- 11.0 years and 43.1 +/- 3.2 repeats). Parkinsonian SCA2 responded well to levodopa. CONCLUSIONS: We conclude that SCA2 is a minor cause of familial parkinsonism, particularly in Taiwan. The parkinsonian phenotype is associated predominantly with a shorter abnormal range of CAG repeat lengths and older onset age. Because of the clinical resemblance among familial parkinsonisms, we suggest that SCA2 should be excluded in cases of familial parkinsonism.
Chin-Song Lu; Yah-Huei Wu Chou; Pei-Chi Kuo; Hsiu-Chen Chang; Yi-Hsin Weng
Related Documents :
16356097 - Primary hyperparathyroidism as the leading symptom in a patient with a y791f ret mutation.
8474067 - Familial systemic lupus erythematosus characterized by digital ischemia.
19195917 - A tularemia outbreak in an extended family in tokat province, turkey: observing the att...
9987547 - Therapeutic paralysis of critically ill trauma patients: perceptions of patients and th...
7301237 - Eclampsia. i. observations from 67 recent cases.
10361917 - Trends in hiv-related consultation in dutch general practice.
Publication Detail:
Type:  Comparative Study; Journal Article    
Journal Detail:
Title:  Archives of neurology     Volume:  61     ISSN:  0003-9942     ISO Abbreviation:  Arch. Neurol.     Publication Date:  2004 Jan 
Date Detail:
Created Date:  2004-01-20     Completed Date:  2004-02-25     Revised Date:  2008-11-21    
Medline Journal Info:
Nlm Unique ID:  0372436     Medline TA:  Arch Neurol     Country:  United States    
Other Details:
Languages:  eng     Pagination:  35-8     Citation Subset:  AIM; IM    
Movement Disorders Unit, First Department of Neurology, Chang Gung Memorial Hospital and School of Medicine, Chang Gung University, 199 Tung Hwa N Road, Lin-Ko, Taipei, Taiwan.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Age of Onset
Genetic Variation*
Middle Aged
Nerve Tissue Proteins
Parkinsonian Disorders / complications,  genetics*
Polymerase Chain Reaction
Proteins / genetics
Spinocerebellar Ataxias / complications,  genetics*
Taiwan / epidemiology
Trinucleotide Repeat Expansion / genetics*
Reg. No./Substance:
0/Nerve Tissue Proteins; 0/Proteins; 0/SCA2 protein
Comment In:
Arch Neurol. 2004 Jan;61(1):25-6   [PMID:  14732614 ]

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Good death and bad death in ancient Israel according to biblical lore.
Next Document:  Safety of latest-generation self-expanding stents in patients with NASCET-ineligible severe symptoma...